JPMorgan Chase & Co. lifted its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 348.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,360,529 shares of the company's stock after acquiring an additional 8,051,379 shares during the period. JPMorgan Chase & Co. owned 4.19% of Oscar Health worth $139,246,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. grew its position in shares of Oscar Health by 20.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company's stock valued at $33,940,000 after acquiring an additional 270,223 shares during the period. The Manufacturers Life Insurance Company boosted its position in Oscar Health by 7.3% during the third quarter. The Manufacturers Life Insurance Company now owns 353,072 shares of the company's stock worth $7,489,000 after purchasing an additional 23,943 shares in the last quarter. FMR LLC grew its holdings in Oscar Health by 29.5% in the third quarter. FMR LLC now owns 109,002 shares of the company's stock valued at $2,312,000 after purchasing an additional 24,801 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Oscar Health by 9.2% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,446 shares of the company's stock valued at $561,000 after buying an additional 2,236 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Oscar Health by 29.2% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 353,491 shares of the company's stock worth $7,498,000 after buying an additional 79,801 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on OSCR shares. Jefferies Financial Group started coverage on Oscar Health in a research note on Tuesday, December 10th. They set an "underperform" rating and a $12.00 price objective for the company. Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and dropped their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have issued a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $20.21.
Check Out Our Latest Stock Report on Oscar Health
Oscar Health Stock Performance
OSCR stock traded down $0.62 during trading on Friday, hitting $12.99. The company had a trading volume of 6,528,010 shares, compared to its average volume of 3,803,303. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. The firm has a 50-day moving average price of $14.60 and a 200-day moving average price of $15.75. Oscar Health, Inc. has a 1-year low of $12.25 and a 1-year high of $23.79. The firm has a market cap of $3.25 billion, a PE ratio of -649.18 and a beta of 1.75.
Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, analysts expect that Oscar Health, Inc. will post 0.69 earnings per share for the current year.
Oscar Health Profile
(
Free Report)
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.
See Also
Before you consider Oscar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.
While Oscar Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
